Immunai的动态

#AACR2024 and #AI - as part of our transformative journey to make biopharma R&D more productive, we are leveraging Charles River #CRL to rapidly translate our discoveries into novel drug candidates. Successful leap from in-silico to the wet lab. American Association for Cancer Research #digitaltwins #AI

Hear the latest in #liquidbiopsy sample prep with nRichDX, CSO Dr. Nafiseh Jafari at 4:15 PM CT today at the CANCER GENOMICS CONSORTIUM Annual Meeting in the CGC Science Cafe! Her brief talk is titled, “Maximizing Liquid Biopsy Sensitivity: The Critical Role of Pre-Analytical Steps” See you there. #CGCAnnual2024 #cfDNA #cfRNA #CTCs #OncologyResearch #CancerResearch

Peer review is a vital part of the medical and scientific publishing process, and researchers who carry out these tasks deserve much greater recognition than they currently receive. To read the interview from Translational Lung Cancer Research, please visit: https://lnkd.in/ehN7WNSH ?#medicine #research #scientificpublication #medicalcommunications

?? Imagine a world where the adverse effects of radiation on healthy tissues during cancer treatment are a thing of the past. We are excited to share our latest publication in the International Journal of Molecular Sciences: "Natural Guardians: Natural Compounds as Radioprotectors in Cancer Therapy." ?? This work would not have been possible without the invaluable contributions of Dorota Formanowicz, whom we would like to thank very much for her cooperation. This research is also the culmination of a dedicated team effort from Anna Stasi?owicz-Krzemień, Anna Go?ciniak, and the unparalelled supervisor Prof. Judyta Cielecka-Piontek. ?? Our comprehensive review delves into the untapped potential of natural compounds as powerful radioprotectors. By identifying effective, non-toxic solutions, our study uncovers a range of natural substances that could transform cancer therapy, paving the way for safer and more effective treatments. ? Read the full article here: https://lnkd.in/dxi_vm82 ???? #CancerResearch #Radiotherapy #NaturalCompounds #Radioprotection #Oncology #ScientificPublication #MedicalScience #UMP #ResearchInnovation #HealthScience

Happy to finally share our protocol for combined #immunophenotyping and #proteinprofiling at single-cell level! The protocol builds on earlier work, but took years of collaborative efforts to develop and optimize. We apply it for #biomarker discovery in #CLL, with the aim to discover predictive markers that can guide #precisionmedicine. Looking forward to sharing the results next! Link to the open access article ?? https://lnkd.in/d4NtEpUC Johanne Uthus Hermansen, #YanpingYin, Idun Dale Rein, MATRIX - Norwegian Centre for Clinical Cancer Research, Kreftforeningen, Norges forskningsr?d

Biological basis of cancer disparities, the cancer macroenvironment, systems level analyses of cancer biology and progression, and mechanisms of resistance—read the editorial by Editor-in-Chief Christine Iacobuzio-Donahue, MD, PhD, to discover why these four areas of convergence research are of particular interest to Cancer Research: https://bit.ly/3UI99Qz

Final throwback to AACR ? To wrap up our series looking back at the highlights of AACR, we have Dr Arutha Kulasinghe presenting the work of his group at The University of Queensland, where they performed spatial profiling on Akoya Biosciences, Inc.’s Phenocycler Fusion with Navinci’s isPLA technology, enabling the idetification of 'immune cell rivers' of interactions in the TME. Watch Arutha's presentation below, and follow the link to read more and view the whole poster: https://lnkd.in/e9VwDjWv American Association for Cancer Research

what do you know about DKFZ? Here some interesting key facts!

Unlock answers to key cancer biology questions by performing single-cell DNA-seq on FFPE samples stored for decades! Access the protocol: https://ow.ly/pyoX50Qp1nL A recent Cell paper published by Drs. Kaile Wang and Nick Navin, “Archival single-cell genomics reveals persistent subclones during DCIS progression,” describes a method that applies the power of the ICELL8? cx Single-Cell System to genomic analysis of archival tumor samples. This exciting work led to a user-generated protocol that you can apply to answer key questions in your own research! #CNV #SingleCell #DNAseq #FFPE #cancer #tumor

ArteraAI's own Dr. Laura Chang, PhD, Vice President of Business Strategy, was recently invited to speak about our multimodal artificial intelligence (MMAI) #biomarker test at several Swedish institutions, including LUCC - Lund University Cancer Centre's mini-symposium for new #precisionmedicine tools for hormone-dependent cancers and at Translational Cancer Research Day at Ume? University. Learn how we're helping shape the future of #cancertreatment decisions, starting with #prostatecancer: https://artera.ai/ #ArteraOnTheGo